Trial intelligence / Profile preview

Effects of Vancomycin on Simvastatin Pharmacokinetics

NCT03403972Phase 1Completed

Sponsor
Seoul National University Hospital
Start
Dec 2017
Primary completion
Jan 2018
Modality
Cyclic Peptides, Antimicrobial Peptides, Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of simvastatin and vancomycin in hypercholesterolemia, sponsored by Seoul National University Hospital. Primary endpoints: Maximum Plasma Concentration at 7 days and Area Under the Curve at 7 days. Started Dec 2017; status: completed.

02

Drugs

simvastatinvancomycin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT03403972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03403972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call